ZLAB logo

Zai Lab Limited (ZLAB) Company Overview

Profile

Full Name:

Zai Lab Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

China

IPO:

September 20, 2017

Indexes:

Not included

Website:

http://www.zailaboratory.com

Description:

Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines. Based in China, it targets cancer and autoimmune diseases, aiming to improve patient outcomes through advanced therapies and collaborations with global partners.

Key Details

Price

$36.35

Market Cap

$3.94 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$398.99 M(+49.59% YoY)

Annual EPS

-$2.60(+25.71% YoY)

PE Ratio

-

Annual ROE

-31.41%

Annual Debt To Equity

0.16

Beta

-

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 3, 25 B of A Securities
Neutral
Oct 25, 24 Cantor Fitzgerald
Overweight
Oct 21, 24 JP Morgan
Overweight
Aug 7, 24 Cantor Fitzgerald
Overweight
Jul 12, 24 JP Morgan
Overweight
Jul 1, 24 Cantor Fitzgerald
Overweight
Jun 25, 24 Cantor Fitzgerald
Overweight
Feb 29, 24 Citigroup
Buy
Dec 14, 23 Morgan Stanley
Overweight
Nov 30, 23 JP Morgan
Overweight

Screeners with ZLAB included

Growing Shares Outstanding
Mid cap stocks
Chinese stocks
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$36.35
ZLAB price is $36.35

Price All-time High

$191.71
ZLAB price is currently -81.04% below its historical high of $191.71

Price Analysts Target

$51.95
ZLAB price is currently -30.04% lower than the consensus analysts' forecast

Price Most Recent Change

+2.14%
ZLAB price was up +2.14% on Mar 8, 2025

Price YTD Change

+38.79%
ZLAB price is up +38.79% since January 1st

Price 3-Year Change

-2.36%
ZLAB price is down -2.36% over the past 3 years

Market cap

Market Cap

$3.94 B
ZLAB market capitalization is $3.94 billion

Market Cap 3-Year Change

+9.65%
ZLAB market capitalization is up +9.65% over the past 3 years

Market Cap All-time High

$17.08 B
ZLAB market capitalization is currently -76.96% below its historical high of $17.08 billion

Market Cap Sector Rank

87.74%
ZLAB market capitalization is higher than 87.74% of companies in Healthcare sector

Technical

Beta

-
ZLAB beta value is unknown

200-day SMA

$23.90
ZLAB price is currently +52.12% above its 200-day simple moving average

14-day RSI

-
ZLAB 14-day relative strength index value is unknown

30-day Relative Volume

0.95
ZLAB 30-day relative volume is 0.95

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$398.99 M
ZLAB annual revenue is $398.99 million

Annual Revenue Analysts Estimate

$566.38 M
ZLAB annual revenue is currently -29.55% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+49.59%
ZLAB annual revenue is up +49.59% year-on-year

Annual Revenue Sector Rank

73.43%
ZLAB annual revenue is higher than 73.43% of companies in Healthcare sector

Profit

Annual Gross Profit

$251.13 M
ZLAB annual gross profit is $251.13 million

Annual Gross Margin

62.94%
ZLAB annual gross profit margin is 62.94%

Annual Operating Profit

-$273.95 M
ZLAB annual operating income is -$273.95 million

Annual Operating Margin

-68.66%
ZLAB annual operating profit margin is -68.66%

Annual Net Income

-$257.10 M
ZLAB annual net profit is -$257.10 million

Annual Net Margin

-64.44%
ZLAB annual net profit margin is -64.44%

EPS

Annual EPS

-$2.60
ZLAB annual earnings per share is -$2.60

Annual EPS Analysts Estimate

-$1.62
ZLAB annual earnings per share is currently +60.12% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+25.71%
ZLAB annual earnings per share is up +25.71% year-on-year

Annual EPS Sector Rank

36.38%
ZLAB annual earnings per share is higher than 36.38% of companies in Healthcare sector

ROA & ROE

Annual ROA

-23.14%
ZLAB annual return on assets is -23.14%

Annual ROE

-31.41%
ZLAB annual return on equity is -31.41%

EBIT & EBITDA

Annual EBIT

-$254.85 M
ZLAB annual earnings before interest & taxes is -$254.85 million

Annual EBITDA

-$242.99 M
ZLAB annual EBITDA is -$242.99 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ZLAB price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ZLAB price to earnings ratio is unknown

PB Ratio

PB Ratio

4.68
ZLAB price to book ratio is 4.68

PB Ratio Sector Rank

80.72%
ZLAB price to book ratio is higher than 80.72% of companies in Healthcare sector

PS Ratio

PS Ratio

9.86
ZLAB price to sales ratio is 9.86

PS Ratio Sector Rank

78.23%
ZLAB price to sales ratio is higher than 78.23% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.64 B
ZLAB enterprise value is $3.64 billion

Enterprise Value Sector Rank

85.81%
ZLAB enterprise value is higher than 85.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-14.98
ZLAB EV/EBITDA is -14.98

EV/EBITDA Sector Rank

8.58%
ZLAB EV/EBITDA is higher than 8.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.51
ZLAB annual current ratio is 3.51

Annual Quick Ratio

3.38
ZLAB annual quick ratio is 3.38

Leverage

Annual Debt To Equity

0.16
ZLAB annual debt to equity ratio is 0.16

Annual Interest Coverage Ratio

-113.07
ZLAB annual interest coverage ratio is -113.07

Risk & Stability

Piotroski F-Score

2
ZLAB piotroski f-score is 2

Altman Z-Score

4.34
ZLAB altman z-score is 4.34

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.19 B
ZLAB annual total assets is $1.19 billion

Annual Non Current Assets

$135.27 M
ZLAB annual long term assets is $135.27 million

Annual Current Assets

$1.05 B
ZLAB annual total current assets is $1.05 billion

Annual Cash & Cash Equivalents

$449.67 M
ZLAB annual cash & cash equivalents is $449.67 million

Equity

Annual Book Value

$840.90 M
ZLAB annual book value is $840.90 million

Annual Working Capital

$751.10 M
ZLAB annual working capital is $751.10 million

Liabilities

Annual Total Liabilities

$344.86 M
ZLAB annual total liabilities is $344.86 million

Annual Total Long Term Liabilities

$45.47 M
ZLAB annual total long term liabilities is $45.47 million

Annual Current Liabilities

$299.38 M
ZLAB annual total current liabilities is $299.38 million

Annual Accounts Payable

$100.91 M
ZLAB annual accounts payable is $100.91 million

Debt

Annual Total Debt

$153.47 M
ZLAB annual total debt is $153.47 million

Annual Total Debt 1-Year Change

+912.94%
ZLAB annual total debt is up +912.94% year-on-year

Annual Long Term Debt

$13.71 M
ZLAB annual long term debt is $13.71 million

Annual Short Term Debt

$139.76 M
ZLAB annual short term debt is $139.76 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$672.93 M
ZLAB annual total expenses is $672.93 million

Annual Operating Expenses

$525.08 M
ZLAB annual total operating expenses is $525.08 million

Annual Cost Of Goods Sold

$147.86 M
ZLAB annual cost of goods sold is $147.86 million

Annual SGA

$298.74 M
ZLAB annual SGA is $298.74 million

Annual D&A

$11.86 M
ZLAB annual depreciation & amortization is $11.86 million

Annual Interest Expense

$2.25 M
ZLAB annual interest expense is $2.25 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$214.87 M
ZLAB annual cash flow from operations is -$214.87 million

Annual CFO 1-Year Change

-8.42%
ZLAB annual cash flow from operations is down -8.42% year-on-year

Annual CFI

-$375.19 M
ZLAB annual cash flow from investing activities is -$375.19 million

Annual CFI 1-Year Change

-3381.75%
ZLAB annual cash flow from investing activities is down -3381.75% year-on-year

Annual CFF

$349.89 M
ZLAB annual cash flow from financing activities is $349.89 million

Annual CFF 1-Year Change

+5538.97%
ZLAB annual cash flow from financing activities is up +5538.97% year-on-year

Free CashFlow

Annual FCF

-$276.39 M
ZLAB annual free cash flow is -$276.39 million

Annual FCF 1-Year Change

-33.74%
ZLAB annual free cash flow is down -33.74% year-on-year

CAPEX

Annual CAPEX

$61.52 M
ZLAB annual capital expenditures is $61.52 million

Annual CAPEX 1-Year Change

+624.56%
ZLAB annual capital expenditures is up +624.56% year-on-year

Institutional Ownership

Similar stocks

CRSP logo
CRISPR Therapeutics AG (CRSP)
ADMA logo
ADMA Biologics (ADMA)
ACLX logo
Arcellx (ACLX)
OGN logo
Organon & Co (OGN)
OSCR logo
Oscar Health (OSCR)
SWTX logo
SpringWorks Therapeutics (SWTX)
ITGR logo
Integer Holdings (ITGR)
PRGO logo
Perrigo (PRGO)
PTCT logo
PTC Therapeutics (PTCT)

FAQ

  • What is the ticker symbol for Zai Lab Limited?
  • Does Zai Lab Limited pay dividends?
  • What sector is Zai Lab Limited in?
  • What industry is Zai Lab Limited in?
  • What country is Zai Lab Limited based in?
  • When did Zai Lab Limited go public?
  • Is Zai Lab Limited in the S&P 500?
  • Is Zai Lab Limited in the NASDAQ 100?
  • Is Zai Lab Limited in the Dow Jones?
  • When was Zai Lab Limited's last earnings report?
  • When does Zai Lab Limited report earnings?
  • Should I buy Zai Lab Limited stock now?

What is the ticker symbol for Zai Lab Limited?

The ticker symbol for Zai Lab Limited is NASDAQ:ZLAB

Does Zai Lab Limited pay dividends?

No, Zai Lab Limited does not pay dividends

What sector is Zai Lab Limited in?

Zai Lab Limited is in the Healthcare sector

What industry is Zai Lab Limited in?

Zai Lab Limited is in the Biotechnology industry

What country is Zai Lab Limited based in?

Zai Lab Limited is headquartered in China

When did Zai Lab Limited go public?

Zai Lab Limited's initial public offering (IPO) was on September 20, 2017

Is Zai Lab Limited in the S&P 500?

No, Zai Lab Limited is not included in the S&P 500 index

Is Zai Lab Limited in the NASDAQ 100?

No, Zai Lab Limited is not included in the NASDAQ 100 index

Is Zai Lab Limited in the Dow Jones?

No, Zai Lab Limited is not included in the Dow Jones index

When was Zai Lab Limited's last earnings report?

Zai Lab Limited's most recent earnings report was on Feb 27, 2025

When does Zai Lab Limited report earnings?

The next expected earnings date for Zai Lab Limited is May 8, 2025

Should I buy Zai Lab Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions